Losartan Potassium
Product Images NDC 53002-2643
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 53002-2643). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (92296151 E507 41b4 A040 C01b87ecb982 02)
This appears to be a graphical representation of data related to a study on the effectiveness of Atenolol and Losartan Potassium Tablets in reducing risk for some sort of primary endpoint. The data shows an "Adjusted Risk Reduction" of 13% with a p-value of 0.021. The x-axis appears to represent study months, while the y-axis may represent the percentage of patients with the primary endpoint. Without additional context or information, it is difficult to determine the exact nature of the study or the primary endpoint.*
Figure 3 (92296151 E507 41b4 A040 C01b87ecb982 03)
Figure 4 (92296151 E507 41b4 A040 C01b87ecb982 04)
Figure 5 (92296151 E507 41b4 A040 C01b87ecb982 05)
Figure 6 (92296151 E507 41b4 A040 C01b87ecb982 06)
Figure 6 (92296151 E507 41b4 A040 C01b87ecb982 07)
Label Image (Lbl530022643)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.